October 17, 2023
Company Description: Yinuoke is a biotech company developing First-in-Concept therapies for cancer patients who have exhausted available therapies based on a deep and unique understanding of cancer biology and immunology. We are developing a pipeline with multiple innovative therapeutic products aiming to reshape the care of terminal cancer.
CEO/Top Company Official
Lead Product in Development
YNK105: small molecule drug for cancer cachexia; IND-enabling YH101: FIC antibody drug for cancer and cancer cachexia: IND-enabling
Development Phase of Primary Product
Number Of Unlicensed Products